Bayer: to make several presentations at ECR
(CercleFinance.com) - Bayer will present advances in its comprehensive radiology portfolio at the European Congress of Radiology (ECR) 2025, to be held from 26 February to 2 March 2025 in Vienna, Austria.
The focus will be on advances in contrast agent and injector development, as well as digital and artificial intelligence (AI) innovations.
The first detailed Phase III data from the investigational MRI contrast agent gadoquatrane will be presented.
The group will also present updates to the MEDRAD TM Centargo CT injection system.
At ECR, Bayer will introduce Systalyze, an MIT (Massachusetts Institute of Technology) spin-off, as a new collaboration partner on Bayer's AI Innovation Platform (AIIP), which aims to support the development teams of healthcare organizations and startups from idea to launch of AI-based software solutions.
Copyright (c) 2025 CercleFinance.com. All rights reserved.
The focus will be on advances in contrast agent and injector development, as well as digital and artificial intelligence (AI) innovations.
The first detailed Phase III data from the investigational MRI contrast agent gadoquatrane will be presented.
The group will also present updates to the MEDRAD TM Centargo CT injection system.
At ECR, Bayer will introduce Systalyze, an MIT (Massachusetts Institute of Technology) spin-off, as a new collaboration partner on Bayer's AI Innovation Platform (AIIP), which aims to support the development teams of healthcare organizations and startups from idea to launch of AI-based software solutions.
Copyright (c) 2025 CercleFinance.com. All rights reserved.